Aller au contenu principal

Hematologic disease


Hematologic disease


Hematologic diseases are disorders which primarily affect the blood and blood-forming organs. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease and complications from chemotherapy or transfusions.

Myeloid

  • Hemoglobinopathies (congenital abnormality of the hemoglobin molecule or of the rate of hemoglobin synthesis)
    • Sickle cell disease
    • Thalassemia
    • Methemoglobinemia
  • Anemias (lack of red blood cells or hemoglobin)
    • Iron-deficiency anemia
    • Megaloblastic anemia
      • Vitamin B12 deficiency
        • Pernicious anemia
      • Folate deficiency
    • Hemolytic anemias (destruction of red blood cells)
      • Genetic disorders of RBC membrane
        • Hereditary spherocytosis
        • Hereditary elliptocytosis
        • Congenital dyserythropoietic anemia
      • Genetic disorders of RBC metabolism
        • Glucose-6-phosphate dehydrogenase deficiency (G6PD)
        • Pyruvate kinase deficiency
      • Immune mediated hemolytic anemia (direct Coombs test is positive)
        • Autoimmune hemolytic anemia
          • Warm antibody autoimmune hemolytic anemia
            • Idiopathic
            • Systemic lupus erythematosus (SLE)
            • Evans syndrome (antiplatelet antibodies and hemolytic antibodies)
          • Cold autoimmune hemolytic anemia
            • Cold agglutinin disease
            • Paroxysmal cold hemoglobinuria (rare)
            • Infectious mononucleosis
        • Alloimmune hemolytic anemia
          • Hemolytic disease of the newborn (HDN)
            • Rh disease (Rh D)
            • ABO hemolytic disease of the newborn
            • Anti-Kell hemolytic disease of the newborn
            • Rhesus c hemolytic disease of the newborn
            • Rhesus E hemolytic disease of the newborn
            • Other blood group incompatibility (RhC, Rhe, Kid, Duffy, MN, P and others)
        • Drug induced immune mediated hemolytic anemia
          • Penicillin (high dose)
          • Methyldopa
      • Hemoglobinopathies (where these is an unstable or crystalline hemoglobin)
      • Paroxysmal nocturnal hemoglobinuria (rare acquired clonal disorder of red blood cell surface proteins)
      • Direct physical damage to RBCs
        • Microangiopathic hemolytic anemia
        • Secondary to artificial heart valve(s)
    • Aplastic anemia
      • Fanconi anemia
      • Diamond–Blackfan anemia (inherited pure red cell aplasia)
      • Acquired pure red cell aplasia
  • Decreased numbers of cells
    • Myelodysplastic syndrome
    • Myelofibrosis
    • Neutropenia (decrease in the number of neutrophils)
    • Agranulocytosis
    • Glanzmann's thrombasthenia
    • Thrombocytopenia (decrease in the number of platelets)
      • Idiopathic thrombocytopenic purpura (ITP)
      • Thrombotic thrombocytopenic purpura (TTP)
      • Heparin-induced thrombocytopenia (HIT)
  • Myeloproliferative disorders (Increased numbers of cells)
    • Polycythemia vera (increase in the number of cells in general)
    • Erythrocytosis (increase in the number of red blood cells)
    • Leukocytosis (increase in the number of white blood cells)
    • Thrombocytosis (increase in the number of platelets)
    • Myeloproliferative disorder
    • Transient myeloproliferative disease
  • Coagulopathies (disorders of bleeding and coagulation)
    • Thrombocytosis
    • Recurrent thrombosis
    • Disseminated intravascular coagulation
    • Disorders of clotting proteins
      • Hemophilia
        • Hemophilia A
        • Hemophilia B (also known as Christmas disease)
        • Hemophilia C
      • Von Willebrand disease
      • Disseminated intravascular coagulation
      • Protein S deficiency
      • Antiphospholipid syndrome
    • Disorders of platelets
      • Thrombocytopenia
      • Glanzmann's thrombasthenia
      • Wiskott–Aldrich syndrome

Hematological malignancies

  • Hematological malignancies
    • Lymphomas
      • Hodgkin's disease
      • Non-Hodgkin's lymphoma {includes the next five entries}
        • Burkitt's lymphoma
        • Anaplastic large cell lymphoma
        • Splenic marginal zone lymphoma
        • Hepatosplenic T-cell lymphoma
        • Angioimmunoblastic T-cell lymphoma (AILT)
    • Myelomas
      • Multiple myeloma
      • Waldenström macroglobulinemia
      • Plasmacytoma
    • Leukemias increased WBC
      • Acute lymphocytic leukemia (ALL)
      • Chronic lymphocytic leukemia (CLL){now included in theCLL/SCLL type NHL}
      • Acute myelogenous leukemia (AML)
      • Acute megakaryoblastic leukemia (AMKL), a sub-type of acute myelogenous leukemia
      • Chronic Idiopathic Myelofibrosis (MF)
      • Chronic myelogenous leukemia (CML)
      • T-cell prolymphocytic leukemia (T-PLL)
      • B-cell prolymphocytic leukemia (B-PLL)
      • Chronic neutrophilic leukemia (CNL)
      • Hairy cell leukemia (HCL)
      • T-cell large granular lymphocyte leukemia (T-LGL)
      • Aggressive NK-cell leukemia

Miscellaneous

  • Hemochromatosis
  • Asplenia
  • Hypersplenism
    • Gaucher's disease
  • Monoclonal gammopathy of undetermined significance
  • Hemophagocytic lymphohistiocytosis
  • Tempi syndrome

Hematological changes secondary to non-hematological disorders

  • Anemia of chronic disease
  • Infectious mononucleosis
  • AIDS
  • Malaria
  • Leishmaniasis

References

External links

  • https://web.archive.org/web/20100527085120/http://hematologic.niddk.nih.gov/info/index.htm

Text submitted to CC-BY-SA license. Source: Hematologic disease by Wikipedia (Historical)



INVESTIGATION